Integrating single-cell and bulk transcriptomes to reveal prognostic and immunological features of ecDNA-related genes in osteosarcoma
Cancer Immunology, Immunotherapy · 28.04.2026 · 75 (5)
DOI: 10.1007/s00262-026-04383-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 28.04.2026. Verfasst von Jinyan Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, People's Republic of China. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms, Extrachromosomal DNA, Transcriptome. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science & Technology Development Fund of Tianjin Education Commission for Higher Education, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine.
Abstract (Originalsprache)
Background
The role of extrachromosomal DNA (ecDNA)-related genes in osteosarcoma remains largely unexplored. The aim of this study is to investigate the association between ecDNA-related genes and prognosis and tumor microenvironment (TME) in osteosarcoma.
Methods
Differential gene expression analysis of GEO datasets was conducted to identify ecDNA-related genes in osteosarcoma. Based on bulk RNA-seq data, a novel ecDNA-related Gene Prognostic Score Model (EGPSM) was developed using an integrated framework of 101 machine learning algorithms, which was validated in training, testing, and external cohorts. The associations between risk scores, prognosis, and TME characteristics were comprehensively evaluated. Single-cell RNA sequencing (scRNA-seq) data were further analyzed to elucidate the relationship between EGPSM, pro-tumor behaviors, and immune modulation in osteosarcoma, as well as to identify key prognostic genes involved in tumor progression. Lastly, we conducted in vitro and in vivo assays to characterize the biological roles of MTDH and to elucidate its regulatory effects on CD8⁺ T cell function.
Results
A robust EGPSM was constructed, demonstrating superior predictive accuracy with a maximum C-index of 0.803. High-risk patients exhibited poorer survival, higher metastatic potential, and an "immune-cold" TME characterized by diminished CD8⁺ T/NK cell infiltration and impaired effector functions. Single-cell analysis confirmed the enrichment of malignant cells and depletion of T/NK populations with lower effector scores in the high-risk group. MTDH was identified as a key driver; functional assays showed it promotes proliferation and invasion while inhibiting apoptosis. Notably, MTDH knockdown potentiated CD8⁺ T-cell cytotoxicity by increasing the levels of granzyme B, IFN- γ , and perforin.
Conclusion
The newly developed EGPSM represents an effective tool for prognostic assessment and therapeutic stratification in osteosarcoma. MTDH may serve as a promising prognostic biomarker and therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, People's Republic of China.
- State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, National Clinical Research Center for Cancer, Tianjin, 300060, People's Republic of China.
- Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, People's Republic of China.
- Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, People's Republic of China. Zhangchao198409@163.com.
- State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, National Clinical Research Center for Cancer, Tianjin, 300060, People's Republic of China. Zhangchao198409@163.com.
- Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, People's Republic of China. Zhangchao198409@163.com.
Förderung
- National Natural Science Foundation of China
- Science & Technology Development Fund of Tianjin Education Commission for Higher Education
- National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine
Zitieren
APA
Feng, J., Liu, J., Yang, H., Li, Y., Xu, Y., Han, X., Zhang, C., & Wang, G. (2026). Integrating single-cell and bulk transcriptomes to reveal prognostic and immunological features of ecDNA-related genes in osteosarcoma. Cancer Immunology, Immunotherapy, 75(5). https://doi.org/10.1007/s00262-026-04383-2
Vancouver
Feng J, Liu J, Yang H, Li Y, Xu Y, Han X, et al. Integrating single-cell and bulk transcriptomes to reveal prognostic and immunological features of ecDNA-related genes in osteosarcoma. Cancer Immunology, Immunotherapy. 2026;75(5). doi:10.1007/s00262-026-04383-2
BibTeX
@article{Feng2026,
author = {Feng, Jinyan and Liu, Jianchao and Yang, Houzhi and Li, Yiqin and Xu, Yao and Han, Xiuxin and Zhang, Chao and Wang, Guowen},
title = {Integrating single-cell and bulk transcriptomes to reveal prognostic and immunological features of ecDNA-related genes in osteosarcoma},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
volume = {75},
number = {5},
doi = {10.1007/s00262-026-04383-2}
}
EUVIMED